Revolution Beauty Gp - Director/PDMR Shareholding

Revolution Beauty

17/09/2025 07:00

RNS Number : 5940Z

Revolution Beauty Group PLC

17 September 2025

 

Revolution Beauty Group plc

Director/PDMR Dealing

 

Revolution Beauty Group plc (Company), the multi-channel mass beauty brand, has been notified of the following transaction in the Company's shares. This announcement is made in accordance with Article 19(1) of the EU Market Abuse Regulation as incorporated into UK law through the European Union (Withdrawal) Act 2018.

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Iain McDonald
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Revolution Beauty Group plc
b)
LEI
21380083TTJWXK677H17
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BP7L1T61
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£0.0295
333,334
d)
Aggregated information
- Aggregated volume
n/a
- Price
e)
Date of the transaction
2025-09-16
f)
Place of the transaction
AIMX

 

For further information, please contact:

 

Investor Relations

Tom Allsworth, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Panmure Liberum (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Ben Robertson / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBRGDCDDBDGUL